|
KIAA1468 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.199900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.481800E-03 |
| Normal-vs-Stage2 |
2.496000E-03 |
| Normal-vs-Stage3 |
7.83870000000686E-05 |
| Normal-vs-Stage4 |
1.566340E-04 |
| Stage1-vs-Stage2 |
2.625600E-01 |
| Stage1-vs-Stage3 |
7.866100E-02 |
| Stage1-vs-Stage4 |
1.068150E-01 |
| Stage2-vs-Stage3 |
8.963800E-01 |
| Stage2-vs-Stage4 |
7.454800E-01 |
| Stage3-vs-Stage4 |
7.894400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.415200E-04 |
| Normal-vs-AfricanAmerican |
1.490160E-01 |
| Normal-vs-Asian |
9.261700E-03 |
| Caucasian-vs-AfricanAmerican |
4.037400E-01 |
| Caucasian-vs-Asian |
8.376400E-01 |
| AfricanAmerican-vs-Asian |
5.534000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.036900E-04 |
| Normal-vs-Female |
7.228700E-04 |
| Male-vs-Female |
9.116000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.265570E-02 |
| Normal-vs-Age(41-60Yrs) |
5.169200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.563910E-04 |
| Normal-vs-Age(81-100Yrs) |
1.202480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.004020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.939700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.419000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.671000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.392800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.562400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.039900E-02 |
| Classical-VS-Follicular |
3.162200E-02 |
| Classical-VS-Other |
9.087400E-01 |
| Classical-VS-Normal |
9.476200E-03 |
| Tall-VS-Follicular |
6.001400E-01 |
| Tall-VS-Other |
2.804800E-01 |
| Tall-VS-Normal |
1.962990E-04 |
| Follicular-VS-Other |
5.571600E-01 |
| Follicular-VS-Normal |
5.418900E-04 |
| Other-VS-Normal |
2.540600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.838090E-04 |
| Normal-vs-N1 |
1.888370E-02 |
| N0-vs-N1 |
4.307600E-01 |
|
|
